VEVeeva Systems VEEV · NYSE
$310.42 -0.83% (-$2.61)
- Market cap
- $50.9B
- Enterprise value
- $49.2B
- P/E
- 50.1x
- Forward P/E
- 33.0x
- PEG
- 2.1x
- P/S
- 14.7x
- P/FCF
- 30.8x
- EV/EBITDA
- 37.9x
- ROIC
- 10.4%
- Gross margin
- 74.9%
- Net margin
- 29.3%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -1.3x
- Beta
- 0.93
- Free float
- 91.6%
About the company
Veeva Systems Inc. (VEEV) is an American software company specializing in providing cloud-based solutions for the pharmaceutical and biotechnology industries. The company offers integrated platforms for data management, clinical trials, marketing, and collaboration, which help pharmaceutical firms and research institutions improve efficiency and productivity in their processes. With its specialized focus and a wide range of services, Veeva Systems has gained a strong market position and is a preferred partner in the biotechnology sector. Investing in shares of Veeva Systems Inc. (VEEV) can present an interesting opportunity for investors seeking an innovative technology company with a significant presence in the pharmaceutical software domain.
Sector
Technology
Industry
Software - Application
CEO
Peter Gassner
Employees
7,928
Headquarters
Pleasanton
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number